Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt

Background. The introduction of MenAfriVac in campaigns targeting people aged 1–29 years across the African meningitis belt has successfully reduced meningitis incidence and carriage due to Neisseria meningitidis group A (MenA). It is important to consider how best to sustain population protection i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Infect Dis
Prif Awduron: Karachaliou, Andromachi, Conlan, Andrew J. K., Preziosi, Marie-Pierre, Trotter, Caroline L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2015
Pynciau:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639487/
https://ncbi.nlm.nih.gov/pubmed/26553693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ508
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg